Correction: LEF1-mediatedMMP13 gene expression is repressed by SIRT1 inhumanchondrocytes (FASEB Journal (2017) 31 (3116–3125) DOI: 10.1096/fj.201601253R);LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes

FASEB Journal

Volumn 31, Issue 7, 2017, Pages 3116-3125

  Elayyan, Jinan ^a   Lee, Eun Jin ^b   Gabay, Odile ^c   Smith, Christopher A ^d   Qiq, Omar ^a   Reich, Eli ^a   Mobasheri, Ali ^e,f   Henrotin, Yves ^g   Kimber, Susan J ^d   Dvir Ginzberg, Mona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b University of Ulsan College of Medicine   (South Korea)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF SURREY   (United Kingdom)

^f QUEEN S MEDICAL CENTRE   (United Kingdom)

^g UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cartilage; Catabolism; IL 1 ; Inflammation; Osteoarthritis

Indexed keywords

COLLAGENASE 3; INTERLEUKIN 1BETA; LYMPHOID ENHANCER FACTOR 1; NEUTROPHIL COLLAGENASE; NICOTINAMIDE; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA; AGGRECANASE 1; MMP3 PROTEIN, HUMAN; MMP8 PROTEIN, HUMAN; STROMELYSIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ARTICULAR CARTILAGE; CELL DIFFERENTIATION; CHONDROCYTE; CHONDROGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME REPRESSION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ADAMTS4 PROTEIN; ANIMALS; CARTILAGE, ARTICULAR; CHONDROCYTES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; LYMPHOID ENHANCER-BINDING FACTOR 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 8; MICE; MICE, KNOCKOUT; OSTEOARTHRITIS; SIRTUIN 1;

EID: 85021674467     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201601253RERR     Document Type: Erratum

References (49)

1. Millward-Sadler, S. J., Wright, M. O., Davies, L. W., Nuki, G., and Salter, D. M. (2000) Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes. Arthritis Rheum. 43, 2091-2099
2. Caron, J. P., Fernandes, J. C., Martel-Pelletier, J., Tardif, G., Mineau, F., Geng, C., and Pelletier, J. P. (1996) Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. 39, 1535-1544
3. Van de Loo, F. A., Joosten, L. A., van Lent, P. L., Arntz, O. J., and van den Berg, W. B. (1995) Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38, 164-172
4. Mengshol, J. A., Vincenti, M. P., and Brinckerhoff, C. E. (2001) IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res. 29, 4361-4372
5. Pelletier, J. P., Martel-Pelletier, J., and Abramson, S. B. (2001) Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 44, 1237-1247
6. Martel-Pelletier, J., Welsch, D. J., and Pelletier, J. P. (2001) Metalloproteases and inhibitors in arthritic diseases. Best Pract. Res. Clin. Rheumatol. 15, 805-829
7. Wang, X., Manner, P. A., Horner, A., Shum, L., Tuan, R. S., and Nuckolls, G.H. (2004) Regulation of MMP-13 expression by RUNX2 and FGF2 inosteoarthritic cartilage. Osteoarthritis Cartilage 12, 963-973
8. Burrage, P. S., Mix, K. S., and Brinckerhoff, C. E. (2006) Matrix metalloproteinases: role in arthritis. Front. Biosci. 11, 529-543
9. Hedbom, E., and Häuselmann, H. J. (2002) Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell. Mol. Life Sci. 59, 45-53
10. Bondeson, J., Wainwright, S., Hughes, C., and Caterson, B. (2008) The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin. Exp. Rheumatol. 26, 139-145
11. Huang, K., and Wu, L. D. (2008) Aggrecanase and aggrecan degradation in osteoarthritis: a review. J. Int. Med. Res. 36, 1149-1160
12. Naito, S., Shiomi, T., Okada, A., Kimura, T., Chijiiwa, M., Fujita, Y., Yatabe, T., Komiya, K., Enomoto, H., Fujikawa, K., and Okada, Y. (2007) Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol. Int. 57, 703-711
13. Li, W., Cai, L., Zhang, Y., Cui, L., and Shen, G. (2015) Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1andthereby silencingHIF-2a. J.Orthop.Res. 33, 1061-1070
14. Lim, H. D., Kim, Y. S., Ko, S. H., Yoon, I. J., Cho, S. G., Chun, Y. H., Choi, B. J., and Kim, E. C. (2012) Cytoprotective and antiinflammatory effects of melatonin in hydrogen peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model of osteoarthritis via the SIRT1 pathway. J. Pineal Res. 53, 225-237
15. Matsushita, T., Sasaki, H., Takayama, K., Ishida, K., Matsumoto, T., Kubo, S., Matsuzaki, T., Nishida, K., Kurosaka, M., and Kuroda, R. (2013) The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1b in human chondrocytes. J. Orthop. Res. 31, 531-537
16. Takayama, K., Ishida, K., Matsushita, T., Fujita, N., Hayashi, S., Sasaki, K., Tei, K., Kubo, S., Matsumoto, T., Fujioka, H., Kurosaka, M., and Kuroda, R. (2009) SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum. 60, 2731-2740
17. Gagarina, V., Gabay, O., Dvir-Ginzberg, M., Lee, E. J., Brady, J. K., Quon, M. J., andHall, D. J. (2010) SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum. 62, 1383-1392
18. Wang, D., Hu, Z., Hao, J., He, B., Gan, Q., Zhong, X., Zhang, X., Shen, J., Fang, J., and Jiang, W. (2013) SIRT1 inhibits apoptosis of degenerative human disc nucleus pulposus cells through activation of Akt pathway. Age (Dordr.) 35, 1741-1753
19. Jiang, W., Zhang, X., Hao, J., Shen, J., Fang, J., Dong, W., Wang, D., Zhang, X., Shui, W., Luo, Y., Lin, L., Qiu, Q., Liu, B., andHu, Z.(2014) SIRT1 protects against apoptosis by promoting autophagy in degenerative human disc nucleus pulposus cells. Sci. Rep. 4, 7456
20. Lei, M., Wang, J., Xiao, D., Fan, M., Wang, D., Xiong, J., Chen, Y., Ding, Y., and Liu, S. (2012) Resveratrol inhibits interleukin 1b-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-kB activity. Eur. J. Pharmacol. 674, 73-79
21. Kim, S. J., Im, D. S., Kim, S. H., Ryu, J. H., Hwang, S. G., Seong, J. K., Chun, C.H., andChun, J. S. (2002)Beta-catenin regulates expression of cyclooxygenase-2 in articular chondrocytes. Biochem. Biophys. Res. Commun. 296, 221-226
22. Hwang, S.G., Ryu, J.H., Kim, I.C., Jho, E.H., Jung, H.C., Kim, K., Kim, S. J., and Chun, J. S. (2004) Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. J. Biol. Chem. 279, 26597-26604
23. Yun, K., Choi, Y. D., Nam, J. H., Park, Z., and Im, S. H. (2007) NFkappaB regulates Lef1 gene expression in chondrocytes. Biochem. Biophys. Res. Commun. 357, 589-595
24. Yun, K., and Im, S.-H. (2007) Lef1 regulates COX-2 transcription in chondrocytes. Biochem. Biophys. Res. Commun. 364, 270-275
25. Yun, K., and Im, S.H. (2007)Transcriptional regulation ofMMP13 by Lef1 in chondrocytes. Biochem. Biophys. Res. Commun. 364, 1009-1014
26. Yun, K., So, J. S., Jash, A., and Im, S. H. (2009) Lymphoid enhancer binding factor 1 regulates transcription through gene looping. J. Immunol. 183, 5129-5137
27. Dvir-Ginzberg, M., Gagarina, V., Lee, E. J., Booth, R., Gabay, O., and Hall, D. J. (2011) Tumor necrosis factor a-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum. 63, 2363-2373
28. Oppenheimer, H., Gabay, O., Meir, H., Haze, A., Kandel, L., Liebergall, M., Gagarina, V., Lee, E. J., and Dvir-Ginzberg, M. (2012) 75-kd sirtuin 1 blocks tumor necrosis factor a-mediated apoptosis in human osteoarthritic chondrocytes. Arthritis Rheum. 64, 718-728
29. McBurney, M. W., Yang, X., Jardine, K., Hixon, M., Boekelheide, K., Webb, J. R., Lansdorp, P. M., and Lemieux, M. (2003) The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol. Cell. Biol. 23, 38-54
30. Derfoul, A., Miyoshi, A. D., Freeman, D. E., and Tuan, R. S. (2007) Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage 15, 646-655
31. Dvir-Ginzberg, M., Gagarina, V., Lee, E. J., and Hall, D. J. (2008) Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 andnicotinamide phosphoribosyltransferase. J. Biol. Chem. 283, 36300-36310
32. Oldershaw, R. A., Baxter, M. A., Lowe, E. T., Bates, N., Grady, L. M., Soncin, F., Brison, D. R., Hardingham, T. E., and Kimber, S. J. (2010) Directed differentiation of human embryonic stem cells toward chondrocytes. Nat. Biotechnol. 28, 1187-1194
33. Cheng, A., Kapacee, Z., Peng, J., Lu, S., Lucas, R. J., Hardingham, T. E., and Kimber, S. J. (2014) Cartilage repair using human embryonic stem cell-derived chondroprogenitors. Stem Cells Transl. Med. 3, 1287-1294
34. Bar Oz, M., Kumar, A., Elayyan, J., Reich, E., Binyamin, M., Kandel, L., Liebergall, M., Steinmeyer, J., Lefebvre, V., and Dvir-Ginzberg, M. (2016) Acetylation reduces SOX9 nuclear entry and ACAN gene transactivation in human chondrocytes. Aging Cell 15, 499-508
35. Glasson, S. S., Chambers, M.G., Van Den Berg, W.B., and Little, C. B. (2010) The OARSI histopathology initiative: recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 18(Suppl 3), S17-S23
36. Blander, G., and Guarente, L. (2004) The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73, 417-435
37. Sauve, A. A., Wolberger, C., Schramm, V. L., and Boeke, J. D. (2006) The biochemistry of sirtuins. Annu. Rev. Biochem. 75, 435-465
38. Gabay, O., Oppenhiemer, H., Meir, H., Zaal, K., Sanchez, C., and Dvir-Ginzberg, M. (2012) Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann. Rheum. Dis. 71, 613-616
39. Ma, B., van Blitterswijk, C. A., and Karperien, M. (2012) A Wnt/ b-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum. 64, 2589-2600
40. Corr, M. (2008) Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis. Nat. Clin. Pract. Rheumatol. 4, 550-556
41. Miclea, R. L., Siebelt, M., Finos, L., Goeman, J. J., Löwik, C. W., Oostdijk, W., Weinans, H., Wit, J. M., Robanus-Maandag, E. C., and Karperien, M. (2011) Inhibition of Gsk3b in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathway. Osteoarthritis Cartilage 19, 1363-1372
42. Nakamura, Y., Nawata, M., and Wakitani, S. (2005) Expression profiles and functional analyses ofWnt-related genes in human joint disorders. Am. J. Pathol. 167, 97-105
43. Simic, P., Zainabadi, K., Bell, E., Sykes, D. B., Saez, B., Lotinun, S., Baron, R., Scadden, D., Schipani, E., and Guarente, L. (2013) SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating b-catenin. EMBO Mol. Med. 5, 430-440
44. Fujita, N., Matsushita, T., Ishida, K., Kubo, S., Matsumoto, T., Takayama, K., Kurosaka, M., and Kuroda, R. (2011) Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through themodulation of chondrocyte gene expressions. J. Orthop. Res. 29, 511-515
45. Dvir-Ginzberg, M., Mobasheri, A., and Kumar, A. (2016) The role of sirtuins in cartilage homeostasis and osteoarthritis. Curr. Rheumatol. Rep. 18, 43
46. Winnik, S., Stein, S., and Matter, C. M. (2012) SIRT1: an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis. Curr. Vasc. Pharmacol. 10, 693-696
47. Yoshizaki, T., Schenk, S., Imamura, T., Babendure, J. L., Sonoda, N., Bae, E. J., Oh, D.Y., Lu, M., Milne, J. C., Westphal, C., Bandyopadhyay, G., and Olefsky, J. M. (2010) SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 298, E419-E428
48. Yang, S. R., Wright, J., Bauter, M., Seweryniak, K., Kode, A., and Rahman, I. (2007) Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L567-L576
49. Nakamaru, Y., Vuppusetty, C., Wada, H., Milne, J. C., Ito, M., Rossios, C., Elliot, M., Hogg, J., Kharitonov, S., Goto, H., Bemis, J. E., Elliott, P., Barnes, P. J., and Ito, K. (2009) A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J. 23, 2810-2819